The Importance of Mehran Score to Predict Acute Kidney Injury in Patients with TAVI: A Large Multicenter Cohort Study
暂无分享,去创建一个
G. Boriani | L. Vignali | P. Magnavacchi | V. Guiducci | F. Sgura | S. Arrotti | D. Gabbieri | R. Rossi | D. Monopoli | G. Benatti | Giulio Leo | Vernizia Morgante | P. Cataldo | Valerio Siena
[1] S. Emren,et al. Predictive Value of the Modified Mehran Score for Contrast-Induced Nephropathy After Transcatheter Aortic Valve Implantation. , 2023, Angiology.
[2] L. Fimiani,et al. Early acute kidney injury after transcatheter aortic valve implantation: predictive value of currently available risk scores. , 2022, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese.
[3] B. Prendergast,et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. , 2021, European heart journal.
[4] P. Lemos,et al. Performance of Prediction Models for Contrast-Induced Acute Kidney Injury after Transcutaneous Aortic Valve Replacement , 2021, Cardiorenal Medicine.
[5] J. Leipsic,et al. Valve Academic Research Consortium 3: updated endpoint definitions for aortic valve clinical research. , 2021, European heart journal.
[6] Jeroen J. Bax,et al. Valve Academic Research Consortium 3: Updated Endpoint Definitions for Aortic Valve Clinical Research. , 2021, Journal of the American College of Cardiology.
[7] G. Delle-Karth,et al. Evaluating the Association between Contrast Medium Dosage and Acute Kidney Injury in Transcatheter Aortic Valve Replacement Using Different Predictive Models , 2020, Journal of clinical medicine.
[8] P. Stella,et al. Aspirin with or without Clopidogrel after Transcatheter Aortic-Valve Implantation. , 2020, The New England journal of medicine.
[9] G. Boriani,et al. Kidney dysfunction and short term all-cause mortality after transcatheter aortic valve implantation. , 2020, European journal of internal medicine.
[10] P. Stella,et al. Anticoagulation with or without Clopidogrel after Transcatheter Aortic-Valve Implantation. , 2020, The New England journal of medicine.
[11] F. Ruschitzka,et al. Baseline Predictors of Renal Failure in Transcatheter Aortic Valve Implantation. , 2019, The Journal of invasive cardiology.
[12] Jeroen J. Bax,et al. Contemporary Presentation and Management of Valvular Heart Disease: The EURObservational Research Programme Valvular Heart Disease II Survey. , 2019, Circulation.
[13] S. Kaul,et al. 2017 ACC Expert Consensus Decision Pathway for Transcatheter Aortic Valve Replacement in the Management of Adults With Aortic Stenosis: A Report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. , 2017, Journal of the American College of Cardiology.
[14] G. Gargiulo,et al. Renal dysfunction and transcatheter aortic valve implantation outcomes , 2016, Expert review of cardiovascular therapy.
[15] A. Taştan,et al. Predictive Value of the Mehran Score for Contrast-Induced Nephropathy after Transcatheter Aortic Valve Implantation in Patients with Aortic Stenosis , 2016, Cardiorenal Medicine.
[16] M. Mack,et al. Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. , 2016, The New England journal of medicine.
[17] B. Iung,et al. The modern epidemiology of heart valve disease , 2015, Heart.
[18] A. Sato,et al. Effect of the Mehran risk score for the prediction of clinical outcomes after percutaneous coronary intervention. , 2015, Journal of cardiology.
[19] T. Wahlers,et al. Acute kidney injury after transcatheter aortic valve implantation. , 2015, Journal of thoracic disease.
[20] A. Sannino,et al. Impact of postoperative acute kidney injury on clinical outcomes after transcatheter aortic valve implantation: A meta‐analysis of 5,971 patients , 2015, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[21] Maurice Buchbinder,et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis. , 2014, The New England journal of medicine.
[22] L. W. Andersen,et al. The Nordic Aortic Valve Intervention (NOTION) trial comparing transcatheter versus surgical valve implantation: study protocol for a randomised controlled trial , 2013, Trials.
[23] Jennifer Taylor,et al. ESC/EACTS Guidelines on the management of valvular heart disease. , 2012, European heart journal.
[24] P. Leprince,et al. Registry of transcatheter aortic-valve implantation in high-risk patients. , 2012, The New England journal of medicine.
[25] D. Basile,et al. Pathophysiology of acute kidney injury. , 2012, Comprehensive Physiology.
[26] R. Lange,et al. Incidence and predictors of acute kidney injury in patients undergoing transcatheter aortic valve implantation. , 2011, American heart journal.
[27] B. Carabello. Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery , 2011, Current cardiology reports.
[28] G. Stone,et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. , 2004, Journal of the American College of Cardiology.
[29] G. Stone,et al. Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. , 2005, The American journal of cardiology.
[30] D. Morris. Valve disease. , 1979, Medical times.